Mostrar o rexistro simple do ítem

dc.contributor.authorMiranda-Olivos, R.*
dc.contributor.authorBaenas, I.*
dc.contributor.authorSteward, T.*
dc.contributor.authorGranero, R.*
dc.contributor.authorPastor, A.*
dc.contributor.authorSánchez, I.*
dc.contributor.authorJuaneda-Seguí, A.*
dc.contributor.authordel Pino-Gutiérrez, A.*
dc.contributor.authorFernández-Formoso, J.A.*
dc.contributor.authorVilarrasa, N.*
dc.contributor.authorGuerrero-Pérez, F.*
dc.contributor.authorVirgili, N.*
dc.contributor.authorLópez-Urdiales, R.*
dc.contributor.authorJiménez-Murcia, S.*
dc.contributor.authorDe la Torre Fornell, Rafael*
dc.contributor.authorSoriano-Mas, C.*
dc.contributor.authorFernández-Aranda, F.*
dc.date.accessioned2025-09-09T11:22:10Z
dc.date.available2025-09-09T11:22:10Z
dc.date.issued2023
dc.identifier.citationMiranda-Olivos R, Baenas I, Steward T, Granero R, Pastor A, Sánchez I, et al. Exploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity. Molecular Psychiatry. 2023;28(11):4793-800.
dc.identifier.issn1476-5578
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/6546ecef32348009d228e8bd
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21480
dc.description.abstractAnorexia nervosa (AN) is a severe psychiatric disorder characterized by a harmful persistence of self-imposed starvation resulting in significant weight loss. Research suggests that alterations in the nucleus accumbens (NAcc) and circulating endocannabinoids (eCBs), such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), may contribute to increased severity and maladaptive behaviors in AN, warranting an examination of the interplay between central reward circuitry and eCBs. For this purpose, we assessed NAcc functional connectivity and circulating AEA and 2-AG concentrations in 18 individuals with AN and 18 healthy controls (HC) to test associations between circulating eCBs, NAcc functional connectivity, and AN severity, as defined by body mass index (BMI). Decreased connectivity was observed between the NAcc and the right insula (NAcc-insula; pFWE < 0.001) and the left supplementary motor area (NAcc-SMA; pFWE < 0.001) in the AN group compared to HC. Reduced NAcc-insula functional connectivity mediated the association between AEA concentrations and BMI in the AN group. However, in HC, NAcc-SMA functional connectivity had a mediating role between AEA concentrations and BMI. Although no significant differences in eCBs concentrations were observed between the groups, our findings provide insights into how the interaction between eCBs and NAcc functional connectivity influences AN severity. Altered NAcc-insula and NAcc-SMA connectivity in AN may impair the integration of interoceptive, somatosensory, and motor planning information related to reward stimuli. Furthermore, the distinct associations between eCBs concentrations and NAcc functional connectivity in AN and HC could have clinical implications for weight maintenance, with eCBs being a potential target for AN treatment.
dc.description.sponsorshipWe thank CERCA Programme/Generalitat de Catalunya for institutional support. We also want to thank the Institut d'Investigacio Biomedica de Bellvitge (IDIBELL) and the Integrative Pharmacology and Systems Neuroscience research group-Hospital del Mar Research Institute (IMIM). This manuscript and research were supported by grants from Instituto de Salud Carlos III (ISCIII) (FIS PI20/00132) and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERObn and CIBERSAM are both initiatives of ISCIII. Additional support was received from the Delegacion del Gobierno para el Plan Nacional sobre Drogas (2021I031) and Ministerio de Ciencia e Innovacion (grant PID2021-124887OB-I00). Additional funding was received by AGAUR-Generalitat de Catalunya (2021-SGR00824), European Union's Horizon 2020 research and innovation program under Grant agreement no. 847879 (PRIME/H2020, Prevention and Remediation of Insulin Multimorbidity in Europe) and the European Union's Horizon Europe research and innovation program under grant agreement No 101080219 (eprObes). This work was partially supported by Instituto de Salud Carlos III through the grant CM21/00172 (IB) (co-funded by European Social Fund. ESF investing in your future). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021Programme). TS is supported by a National Health and Medical Research Council (NHMRC)/Medical Research Future Fund (MRFF) Investigator Grant (MRF1193736), a Brain & Behavior Research Foundation (BBRF) Young Investigator Grant, and a University of Melbourne McKenzie Fellowship. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshHumans *
dc.subject.meshNucleus Accumbens *
dc.subject.meshAnorexia Nervosa *
dc.subject.meshEndocannabinoids *
dc.subject.meshMagnetic Resonance Imaging *
dc.subject.meshReward *
dc.titleExploring the influence of circulating endocannabinoids and nucleus accumbens functional connectivity on anorexia nervosa severity
dc.typeArtigo
dc.authorsophosMiranda-Olivos, R.; Baenas, I.; Steward, T.; Granero, R.; Pastor, A.; Sánchez, I.; Juaneda-Seguí, A.; del Pino-Gutiérrez, A.; Fernández-Formoso, J.A.; Vilarrasa, N.; Guerrero-Pérez, F.; Virgili, N.; López-Urdiales, R.; Jiménez-Murcia, S.; de la Torre, R.; Soriano-Mas, C.; Fernández-Aranda, F.
dc.identifier.doi10.1038/s41380-023-02253-2
dc.identifier.sophos6546ecef32348009d228e8bd
dc.issue.number11
dc.journal.titleMolecular Psychiatry*
dc.page.initial4793
dc.page.final4800
dc.relation.projectIDInstituto de Salud Carlos III (ISCIII) [FIS PI20/00132]
dc.relation.projectIDFEDER funds/European Regional Development Fund (ERDF), a way to build Europe
dc.relation.projectIDDelegacion del Gobierno para el Plan Nacional sobre Drogas [2021I031]
dc.relation.projectIDMinisterio de Ciencia e Innovacion [PID2021-124887OB-I00]
dc.relation.projectIDAGAUR-Generalitat de Catalunya [2021-SGR00824]
dc.relation.projectIDEuropean Union's Horizon 2020 research and innovation program [847879]
dc.relation.projectIDEuropean Union [101080219]
dc.relation.projectIDInstituto de Salud Carlos III (European Social Fund. ESF investing in your future) [CM21/00172]
dc.relation.projectIDCatalan Institution for Research and Advanced Studies (ICREA-Academia, 2021Programme)
dc.relation.projectIDNational Health and Medical Research Council (NHMRC)/Medical Research Future Fund (MRFF) Investigator Grant [MRF1193736]
dc.relation.projectIDBrain & Behavior Research Foundation (BBRF) Young Investigator Grant
dc.relation.projectIDUniversity of Melbourne McKenzie Fellowship
dc.relation.publisherversionhttps://doi.org/10.1038/s41380-023-02253-2
dc.rights.accessRightsopenAccess*
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number28


Ficheiros no ítem

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem

Attribution 4.0 International (CC BY 4.0)
A non ser que se indique outra cousa, a licenza do ítem descríbese comoAttribution 4.0 International (CC BY 4.0)